Explore

Trendline Trendline
Japanese Pharmaceutical Companies Expand M Activities in U.S. and Europe

Japanese Pharmaceutical Companies Expand M Activities in U.S. and Europe

Japanese Pharmaceutical Companies Expand M Activities in U.S. and Europe
Rapid Read Rapid Read
Book Explores Impact of Ultra-Processed Foods on Health and Obesity

Book Explores Impact of Ultra-Processed Foods on Health and Obesity

A new book titled 'Food Intelligence: The Science of How Food Both Nourishes and Harms Us' by Julia Belluz and Kevin Hall explores the impact of ultra-processed foods (UPFs) on health and obesity. The book builds on Hall's 2019 study, which found that UPFs can lead to overeating and weight gain. The authors argue that the harms of processed foods extend beyond their fat, sugar, or salt content, and criticize the current regulatory framework in the U.S. for its lax control over food additives and supplements. They advocate for tighter regulations and greater transparency to address the 'toxic food environment' that promotes overconsumption.
Trendline Trendline
Eli Lilly's Retatrutide Shows Promising Weight Loss Results in Phase 3 Trial

Eli Lilly's Retatrutide Shows Promising Weight Loss Results in Phase 3 Trial

Eli Lilly's Retatrutide Shows Promising Weight Loss Results in Phase 3 Trial
Rapid Read Rapid Read
Study Reveals Temporary Effects of Tirzepatide on Food Cravings

Study Reveals Temporary Effects of Tirzepatide on Food Cravings

A study conducted by the University of Pennsylvania School of Medicine has provided insights into how tirzepatide, a medication originally developed for Type 2 diabetes, affects the brain's reward center related to food cravings. The research involved a participant with severe obesity and loss of control eating, who experienced a temporary reduction in food cravings while on tirzepatide. However, the effects diminished over time, suggesting that while tirzepatide may help manage food noise and binge eating, its impact is not long-lasting. The study highlights the need for further investigation into the use of GLP-1 and GIP inhibitors for treating eating disorders.
Trendline Trendline
Genentech Unveils Promising Lunsumio Data for Lymphoma Treatment at Medical Conference

Genentech Unveils Promising Lunsumio Data for Lymphoma Treatment at Medical Conference

Genentech Unveils Promising Lunsumio Data for Lymphoma Treatment at Medical Conference
Rapid Read Rapid Read
Research Suggests Timing of Cancer Drug Delivery Could Enhance Survival Rates

Research Suggests Timing of Cancer Drug Delivery Could Enhance Survival Rates

Recent research indicates that the timing of administering cancer drugs, particularly immune checkpoint inhibitors, can significantly impact patient outcomes. The study highlights that administering these drugs in alignment with the body's circadian rhythms, specifically in the morning when immune T cells are more active, may enhance their efficacy. This approach, known as chronotherapy, has shown promising results in improving survival rates for patients with advanced non-small cell lung cancer (NSCLC) and small cell lung cancer. The research, conducted by Zhe Huang and colleagues at Central South University in China, found that patients receiving treatment before 11:30 am had nearly double the survival rate compared to those treated later in the day. The study suggests that this timing could potentially benefit other cancer types as well.
Rapid Read Rapid Read
Kimchi Study Reveals Immune-Boosting Effects Through Single-Cell Analysis

Kimchi Study Reveals Immune-Boosting Effects Through Single-Cell Analysis

A new study conducted by the World Institute of Kimchi has demonstrated the immune-boosting effects of kimchi, a traditional Korean fermented food. Using single-cell transcriptomics, researchers found that kimchi consumption enhances the function of antigen-presenting cells and balances CD4+ T cell differentiation. The study involved overweight adults who consumed either a placebo or kimchi powder over 12 weeks. The findings suggest that kimchi acts as a 'precision regulator' of the immune system, enhancing defense capabilities while suppressing excessive responses.
AP News AP News
Trump approves sale of more advanced Nvidia computer chips used in AI to China

Trump approves sale of more advanced Nvidia computer chips used in AI to China

President Donald Trump says he will allow Nvidia to sell its H200 computer chip used in the development of artificial intelligence to “approved customers” in China
Reuters Reuters
Aware Super CIO warns of 'orange' lights in AI financing as valuations soar

Aware Super CIO warns of 'orange' lights in AI financing as valuations soar

By Scott Murdoch SYDNEY, Dec 9 (Reuters) - The chief investment officer of Australian pension fund Aware Super says there are flashing "orange" lights in some funding arrangements in the global artificial intelligence industry but earnings growth is backing up the sector's current valuations.
Rapid Read Rapid Read
US Approves $3.73 Billion Sale of IBCS and AMRAAMs to Denmark

US Approves $3.73 Billion Sale of IBCS and AMRAAMs to Denmark

The U.S. State Department has approved two significant foreign military sales to Denmark, valued at approximately $3.73 billion. The sales involve the Integrated Battle Command System (IBCS) equipment with Indirect Fire Protection Capability and AIM-120C-8 Advanced Medium Range Air-to-Air Missiles (AMRAAM). The Defense Security Cooperation Agency has provided Congress with the necessary certifications for these transactions. The IBCS package, valued at around $3 billion, includes various military equipment such as launchers, radars, and engagement operations centers. Additionally, the AMRAAM sale, estimated at $730 million, includes 200 missiles and related support equipment. RTX, Lockheed-Martin, Leidos, and Northrop Grumman are the principal contractors for these sales.
Rapid Read Rapid Read
U.S. Offers $10 Million Reward for Information on IRGC-Linked Cyber Unit Leaders

U.S. Offers $10 Million Reward for Information on IRGC-Linked Cyber Unit Leaders

The U.S. State Department has announced a reward of up to $10 million for information leading to the capture of two individuals, Mohammad Bagher Shirinkar and Fatemeh Sedighian Kashi, who are allegedly involved with Shahid Shushtari, a cyber unit under Iran's Revolutionary Guard Corps Cyber-Electronic Command. This unit has been implicated in cyberattacks targeting critical infrastructure across various sectors, including news, shipping, travel, energy, financial, and telecom, in the U.S., Europe, and the Middle East. The group, also known as Emennet Pasargad, has been active since 2018 and has been involved in operations to influence the 2020 U.S. presidential election. The Treasury Department had previously sanctioned the group and its members for these activities.
Reuters Reuters
US bond investors bet on mild easing cycle, stick to middle of curve

US bond investors bet on mild easing cycle, stick to middle of curve

By Gertrude Chavez-Dreyfuss NEW YORK, Dec 8 (Reuters) - Bond investors are positioning for a shallow easing cycle from the Federal Reserve as it gears up for its final policy meeting of 2025, reducing exposure to long-duration Treasuries and rotating into intermediate maturities for juicier returns.